Industry Archives | Frier Levitt

Cigna’s Switch from CareCentrix to Wholly-Owned eviCore May Impact Network Access for IVIG Providers

Brenna Sackman, Esq. and Jesse C. Dresser, Esq. January 13, 2021

In February 2020, Cigna announced that it would be terminating its contract with CareCentrix, the third party administrator that had managed home infusion therapy services for Cigna’s beneficiaries nationwide. The announcement indicated that the... Read More

Failure to Verify Prescriber’s State License Via Computer System Leads to DOJ Action

Martha M. Rumore Pharm.D., Esq., Kendra E. Pannitti, Esq. and Daniel G. Giaquinto, Esq. January 12, 2021

The Department of Justice (“DOJ” or the “Government”) and Bartell Drug, Inc. (“Bartell”), a Washington State pharmacy chain of approximately 70 pharmacies, recently reached a civil settlement in which Bartell agreed to pay a fine... Read More

Pharmacy ALERT: CVS Caremark Nearly Doubles Drugs on “Aberrant Quantities” Product List Effective January 2021

Dae Y. Lee, Esq., Pharm.D CPBS and Harini Bupathi, Esq. January 7, 2021

In 2019, Frier Levitt reported a new dispensing limitation CVS Caremark (“Caremark”) introduced in its retail networks that took effect on January 1, 2020. Specifically, Caremark issued an “Aberrant Product List” that identified... Read More

Blogs & Articles | Community, Retail Pharmacies | COVID-19 Resources | Life Sciences

Emerging Trends in Payor-Mandated White Bagging

Martha M. Rumore Pharm.D., Esq. and Jesse C. Dresser, Esq. January 6, 2021

Over the last several years, several of the nation’s largest insurers, pharmacy benefits managers (PBMs), and specialty pharmacies have combined or consolidated into just a handful of vertically integrated healthcare conglomerates. This... Read More

Blogs & Articles | Home Infusion Providers | Life Sciences | Specialty Pharmacies

Legal and Regulatory Issues in Self-Care Pharmacy Practice

Martha M. Rumore Pharm.D., Esq. January 4, 2021

Frier Levitt Clinician-Attorney and Senior Counsel, Martha M. Rumore, Pharm.D., MS, JD, LLM authored Chapter 4 of Handbook of Nonprescription Drugs titled "Legal and Regulatory Issues in Self-Care Pharmacy Practice" , 20th ed. This is an... Read More

Blogs & Articles | Life Sciences | Pharmacy Law

Frier Levitt Successfully Obtains a $6.25 Million Settlement on Behalf of Its Plan Sponsor Client Against a Pharmacy Benefits Manager

Christopher Caltavuturo, Esq., Dae Y. Lee, Esq., Pharm.D CPBS and Todd Mizeski, Esq. December 23, 2020

Frier Levitt recently obtained a $6.25 Million settlement against a Pharmacy Benefits Manager(“PBM”) on behalf of its Plan Sponsor client (“Plan”). The Plan contracted with the PBM to administer its prescription drug program, and to... Read More

Employment Law Alert: Families First Coronavirus Response Act (FFCRA) set to expire on December 31, 2020; no renewal in sight

Sean E. Sanders, Esq. and Michelle L. Greenberg, Esq. December 21, 2020

Despite the continuing increase in COVID-19 cases and the limit on gatherings, the Families First Coronavirus Response Act (FFCRA) will expire on December 31, 2020. Enacted in March 2020, the FFCRA provided extra expanded leave entitlements to... Read More

Blogs & Articles | COVID-19 Resources | Employment Matters | Healthcare

Opioid Distribution Chain Participants Targeted by DOJ

Dae Y. Lee, Esq., Pharm.D CPBS, Kendra E. Pannitti, Esq. and Danielle N. DelGrosso, Esq. December 21, 2020

As the opioid crisis continues to result in devastating consequences throughout the country, the U.S. Department of Justice (the “DOJ”) is broadening its opioid enforcement to all stakeholders involved in the opioid supply chain including,... Read More

Blogs & Articles | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

How Will the Recently Promulgated CMS and OIG Final Rules Affect My Practice? – Part I

Jonian Rafti, Esq., Daniel B. Frier, Esq. and Theresa M. DiGuglielmo, Esq. December 21, 2020

The Department of Health and Human Services (HHS) recently published the long-awaited new rules related to the Anti-Kickback Statute, Civil Monetary Penalties Law, and the Stark Law (collectively, the “Final Rules”). The Final Rules are part of... Read More

All types of single and multi-specialty medical practice groups | Blogs & Articles | Healthcare | Healthcare Law | Value Based Care

Master the Margin – Pharmacy Influencer Series: Trends in Reimbursement Solutions

Jesse C. Dresser, Esq. December 18, 2020

Frier Levitt Life Sciences Partner, Jesse C. Dresser, Esq. participated in a Master the Margin webinar with Ollin Sykes, CPA and Scotty Sykes, CPA, CFP® , both of Sykes & Company, P.A. to discuss recent trends in reimbursement... Read More

Community, Retail Pharmacies | DIR Fees | Life Sciences | Pharmacy Law | Webinars

Category: Industry